Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Estrogen Signaling and Its Potential as a Target for Therapy in Ovarian Cancer
Simon P. Langdon, C. Simon Herrington, Robert L. Hollis, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1647-1647
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Role of estrogen receptors in health and disease
Peng Chen, Bo Li, Ling Ouyang
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 139
Carboranes as unique pharmacophores in antitumor medicinal chemistry
Yu Chen, Fukuan Du, Liyao Tang, et al.
Molecular Therapy — Oncolytics (2022) Vol. 24, pp. 400-416
Open Access | Times Cited: 71
Estrogen Receptor Signaling in Breast Cancer
Paulina Miziak, Marzena Baran, Ewa Błaszczak, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4689-4689
Open Access | Times Cited: 61
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
Valéria Tavares, Inês Soares Marques, Inês Guerra de Melo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1845-1845
Open Access | Times Cited: 32
Hormonal Therapy for Gynecological Cancers: How Far Has Science Progressed toward Clinical Applications?
Saikat Mitra, Mashia Subha Lami, Avoy Ghosh, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 759-759
Open Access | Times Cited: 60
Current Understanding on Why Ovarian Cancer Is Resistant to Immune Checkpoint Inhibitors
Anna Pawłowska, Anna K. Rekowska, Weronika Kuryło, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10859-10859
Open Access | Times Cited: 25
Estrogens, Estrogen Receptors and Tumor Microenvironment in Ovarian Cancer
Marta Justyna Kozieł, Agnieszka Wanda Piastowska‐Ciesielska
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14673-14673
Open Access | Times Cited: 24
Endometriosis-Associated Ovarian Cancer: From Molecular Pathologies to Clinical Relevance
Sophie Charlotte Steinbuch, Anne-Marie Lüß, Stephanie Eltrop, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4306-4306
Open Access | Times Cited: 9
Synthesis and Anticancer Evaluation of O-Alkylated (E)-Chalcone Derivatives: A Focus on Estrogen Receptor Inhibition
Alwah R. Al-Ghamdi, Wahid U. Ahmed, Reem I. Al-Wabli, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 833-833
Open Access | Times Cited: 1
Exploring the reproductive exposure risks of phthalates and organophosphates in atmospheric particulate matter based on quantitative structure-activity relationships and network toxicology models
Ke Gao, Kai Hua, Shiyuan Wang, et al.
Journal of Hazardous Materials (2025), pp. 137395-137395
Closed Access | Times Cited: 1
A Review of the Clinical Characteristics and Novel Molecular Subtypes of Endometrioid Ovarian Cancer
Shuangfeng Chen, Yuebo Li, Lili Qian, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 33
The prognostic value of MEK pathway–associated estrogen receptor signaling activity for female cancers
Chun Wai Ng, Yvonne T.M. Tsang, David M. Gershenson, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 11, pp. 1875-1884
Open Access | Times Cited: 5
Role of ERβ in the ovary and ovary related diseases
Xuewei Bao, Di Yan, Jing Yang, et al.
Gene (2024) Vol. 927, pp. 148678-148678
Closed Access | Times Cited: 5
Progress in the management of ovarian granulosa cell tumor: A review
Junting Li, Ran Chu, Zhongshao Chen, et al.
Acta Obstetricia Et Gynecologica Scandinavica (2021) Vol. 100, Iss. 10, pp. 1771-1778
Open Access | Times Cited: 28
Estrogen receptor α revised: Expression, structure, function, and stability
Makoto Habara, Midori Shimada
BioEssays (2022) Vol. 44, Iss. 12
Closed Access | Times Cited: 21
Cancer-biomarkers associated with sex hormone receptors and recent therapeutic advancements: a comprehensive review
Suvitha Anbarasu, Anand Anbarasu
Medical Oncology (2023) Vol. 40, Iss. 6
Closed Access | Times Cited: 12
The Co-Expression of Estrogen Receptors ERα, ERβ, and GPER in Endometrial Cancer
Marko Hojnik, Maša Sinreih, Maja Anko, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 3009-3009
Open Access | Times Cited: 11
Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan
Miki Gibo, Seiji Kojima, Akinori Fujisawa, et al.
Cureus (2024)
Open Access | Times Cited: 4
Gender differences in gliomas: from epidemiological trends to changes at the hormonal and molecular levels
Jiale Yin, G H Liu, Yue Zhang, et al.
Cancer Letters (2024) Vol. 598, pp. 217114-217114
Closed Access | Times Cited: 4
Estrogen receptor expression in human tumors: A tissue microarray study evaluating more than 18,000 tumors from 149 different entities.
Florian Viehweger, J. Gusinde, Nicolai Leege, et al.
Human Pathology (2025) Vol. 157, pp. 105757-105757
Closed Access
Expression of HECTD3 in Epithelial Ovarian Cancer and Its Effect on Platinum Resistance
云婷 周
Advances in Clinical Medicine (2025) Vol. 15, Iss. 04, pp. 1989-2001
Closed Access
In situ multifunctional gel for hormone-immune therapy of ovarian cancer and prevention of postoperative adhesion
Yankun Zhang, Yanbin Shi, Hengchang Zang, et al.
Chemical Engineering Journal (2025), pp. 163135-163135
Closed Access
Natural product–based drug nanodelivery systems in cancertherapy
Melek Yüce, Y. Esra Albayrak
Studies in natural products chemistry (2025), pp. 41-104
Closed Access
Estrogen Receptor-Beta2 (ERβ2)–Mutant p53–FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC)
Chetan C. Oturkar, Nishant Gandhi, Pramod Rao, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1120-1120
Open Access | Times Cited: 16
Impairment of steroidogenesis and follicle development after bisphenol A exposure during pregnancy and lactation in the ovaries of Mongolian gerbils aged females
Thalles Fernando Rocha Ruiz, Vitor Grigio, Luara Jesus Ferrato, et al.
Molecular and Cellular Endocrinology (2023) Vol. 566-567, pp. 111892-111892
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top